Seo K, Choi J
Genomics Inform. 2025; 23(1):6.
PMID: 39994831
PMC: 11853700.
DOI: 10.1186/s44342-024-00034-z.
Kapadia B, Roychowdhury A, Kayastha F, Lee W, Nanaji N, Windle J
Neoplasia. 2025; 62:101144.
PMID: 39987653
PMC: 11905846.
DOI: 10.1016/j.neo.2025.101144.
Staniek J, Rizzi M
Immunol Rev. 2025; 330(1):e70004.
PMID: 39917832
PMC: 11803499.
DOI: 10.1111/imr.70004.
Huang P, Yang G, Zhang P, Zhu Y, Guan Y, Sun J
Cell Death Dis. 2025; 16(1):43.
PMID: 39863600
PMC: 11763251.
DOI: 10.1038/s41419-025-07352-2.
Kitata R, Velickovic M, Xu Z, Zhao R, Scholten D, Chu R
Nat Commun. 2025; 16(1):547.
PMID: 39805815
PMC: 11730317.
DOI: 10.1038/s41467-024-54643-x.
Cord blood platelet-rich plasma: proteomics analysis for ophthalmic applications.
Savastano M, Giannuzzi F, Savastano A, Cestrone V, Boselli F, Carla M
Clin Proteomics. 2025; 22(1):1.
PMID: 39754030
PMC: 11699781.
DOI: 10.1186/s12014-024-09524-2.
Structure-guided design and evaluation of CRM197-scaffolded vaccine targeting GnRH for animal immunocastration.
Duan Y, Tang X, Liu S, Cui W, Li M, Tang S
Appl Microbiol Biotechnol. 2024; 108(1):507.
PMID: 39520573
PMC: 11550287.
DOI: 10.1007/s00253-024-13348-3.
B cells: roles in physiology and pathology of pregnancy.
Liu J, Zeng Q, Duan Y, Yeung W, Li R, Ng E
Front Immunol. 2024; 15:1456171.
PMID: 39434884
PMC: 11491347.
DOI: 10.3389/fimmu.2024.1456171.
Multi-dataset identification of innovative feature genes and molecular mechanisms in keratoconus.
Lyu N, Dai Y, Wu J, Fan Y, Lyu Z, Gu J
J Cell Mol Med. 2024; 28(18):e70079.
PMID: 39300613
PMC: 11412914.
DOI: 10.1111/jcmm.70079.
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACE.
Camus V, Viennot M, Viailly P, Drieux F, Veresezan E, Bobee V
Blood Adv. 2024; 9(1):101-115.
PMID: 39293080
PMC: 11742575.
DOI: 10.1182/bloodadvances.2024013723.
Both sides now: evolutionary traits of antigens and B cells in tolerance and activation.
Hong Y, Kwak K
Front Immunol. 2024; 15:1456220.
PMID: 39185403
PMC: 11341355.
DOI: 10.3389/fimmu.2024.1456220.
PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration.
Chen S, Zhou C, Dai J, Xu Q, Chen Y, Hu Z
Curr Cancer Drug Targets. 2024; 25(2):159-169.
PMID: 39177130
DOI: 10.2174/0115680096307100240801095132.
Inhibition of B cell receptor signaling induced by the human adenovirus species D E3/49K protein.
Hildenbrand A, Cramer P, Bertolotti M, Kaiser N, Klasener K, Nickel C
Front Immunol. 2024; 15:1432226.
PMID: 39139562
PMC: 11321000.
DOI: 10.3389/fimmu.2024.1432226.
MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation.
Chen Y, Kincaid R, Bastin K, Fachko D, Skalsky R
PLoS Pathog. 2024; 20(6):e1011970.
PMID: 38885264
PMC: 11213311.
DOI: 10.1371/journal.ppat.1011970.
Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer.
Viet-Nhi N, Minh Quan T, Cong Truc V, Anh Bich T, Hoang Nam P, Le N
Int J Mol Sci. 2024; 25(5).
PMID: 38473938
PMC: 10931552.
DOI: 10.3390/ijms25052691.
B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.
Schmid V, Hobeika E
Front Oncol. 2024; 14:1339620.
PMID: 38469232
PMC: 10926848.
DOI: 10.3389/fonc.2024.1339620.
MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.
Ali A, Mahla S, Reza V, Hossein A, Bahareh K, Mohammad H
EJHaem. 2024; 5(1):191-205.
PMID: 38406506
PMC: 10887358.
DOI: 10.1002/jha2.849.
Advances on adaptive immune responses affected by infectious bursal disease virus in chicken.
Zhang T, Wang S, Liu Y, Qi X, Gao Y
Front Immunol. 2024; 14:1330576.
PMID: 38268928
PMC: 10806451.
DOI: 10.3389/fimmu.2023.1330576.
B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.
Tkachenko A, Kupcova K, Havranek O
Int J Mol Sci. 2024; 25(1).
PMID: 38203179
PMC: 10779339.
DOI: 10.3390/ijms25010010.
Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle.
Zhuang X, Liu B, Long J, Wang H, Yu J, Ji X
Clin Transl Oncol. 2023; 26(4):936-950.
PMID: 37783922
DOI: 10.1007/s12094-023-03326-y.